Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Ethicon Morcellator Lawsuit Filed Over Death from Disseminated Uterine Cancer December 11, 2014 Irvin Jackson Add Your Comments The family of a Missouri woman has filed one of the latest in a growing number uterine cancer lawsuits over power morcellators, alleging that a device manufactured by Johnson & Johnson’s Ethicon subsidiary caused cancer to be disseminated during a robotic hysterectomy. The complaint (PDF) was filed in the U.S. District Court for the Western District of Missouri on December 3, following the death of Carl Cecilia Merrill in August due to the spread of a rare, malignant cancer called leiomyosarcoma. Merrill underwent a robot-assisted hysterectomy and uterine fibroid removal surgery in December 2012, at which time an Ethicon Gynecare morcellator was used to allow the doctors to remove the uterus and fibroid laparoscopically, through a minimal incision in the abdomen. However, the device allegedly caused undiagnosed uterine cancer to be disseminated throughout her peritoneal cavity, rapidly upstaging the cancer from its earliest, and most treatable stage, to its most deadly. Learn More About Hysterectomy Morcellation Cancer Lawsuits Power morcellators used during a laparoscopic hysterectomy or uterine fibroid surgery may cause the spread of aggressive cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Hysterectomy Morcellation Cancer Lawsuits Power morcellators used during a laparoscopic hysterectomy or uterine fibroid surgery may cause the spread of aggressive cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The wrongful death lawsuit was filed by Merrill’s life partner, Terry Shafer, alleging that Ethicon knew or should have known about the significant uterine cancer risks associated with their power morcellators, but failed to provide adequate warnings for consumers or the medical community. The complaint also lists Merrill’s sister, Doris Simpson, as a plaintiff. Uterine Cancer Dissemination Risk from Morcellators Concerns about the risk of power morcellators disseminating uterine cancer have gained widespread attention in the medical community over the past year, with FDA estimates suggesting that about 1 in 350 women undergoing laparoscopic uterine fibroid removal may have unsuspected sarcoma cells in the fibroids. Since there is no way for doctors to detect the uterine cancer before using morcellators to grind up the uterus or uterine fibroids, the FDA urged doctors to avoid using the devices for laparoscopic hysterectomy or myomectomy procedures in April 2014. Following an FDA advisory panel meeting this summer, all Ethicon power morcellators were recalled by the manufacturer, which acknowledged at that time that the devices pose an unreasonable risk of disseminating uterine cancer. The Johnson & Johnson subsidiary called for hospitals to voluntarily return all laparoscopic surgery morcellators, indicating that it will no longer sell the devices since there is no way to make them safe. Following an FDA investigation into the uterine cancer risk with power morcellators, the agency announced November 24 that it is adding a black box warning to uterine morcellators that remain on the market, which is the strongest warning that can be place on a medical device. In addition to the new warning, the FDA indicated that power morcellators should not be used with women near menopause or post-menopausal, or in women who could have tissue removed through the vagina or via a small incision. The contraindication essentially prohibits the use of the devices in the vast majority of women who undergo laparoscopic uterine morcellation procedures. Power Morcellator Cancer Litigation The Beverly lawsuit Ethicon of negligence, breach of warranty, strict liability, fraudulent misrepresentation and omission, negligent misrepresentation, and violation of Missouri consumer protection laws, seeking both compensatory and punitive damages. The complaint joins a growing number of similar uterine cancer lawsuits that are now being pursued on behalf of individuals nationwide diagnosed with disseminated uterine cancer following a minimally invasive, laparoscopic surgery. Plaintiffs allege that the rapid spread of leiomyosarcoma, endometrial stromal sarcoma or other uterine cancers may have been avoided if any number of different alternative treatment options available for women with symptomatic uterine fibroids had been used, including traditional surgical hysterectomy performed vaginally or abdominally, catheter-based blocking of the uterine artery, high-intensity focused ultrasound, drug therapy and laparoscopic hysterectomy or myomectomy without use of morcellation. Tags: Cancer, Ethicon, Gynecare, Johnson & Johnson, Leiomyosarcoma, Missouri, Morcellation, Morcellator, Uterine Fibroid Removal More Morcellation Lawsuit Stories FDA Issues New Guidelines, Safety Communication On Use Of Power Morcellators February 26, 2020 Morcellator Use Tied To Increased Risk Of Death In Women With Uterine Sarcoma: Study September 30, 2019 CDC Weighs New Guidelines For Gynecologists For Detecting Uterine Cancer May 11, 2018 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (Posted: today) Six women have filed a joint, multiplaintiff BioZorb tissue marker lawsuit, all indicating that they suffered injuries and complications due to the recalled device’s defective design. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025) 6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: yesterday) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025) MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 4 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Morcellator Use Tied To Increased Risk Of Death In Women With Uterine Sarcoma: Study September 30, 2019
Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (Posted: today) Six women have filed a joint, multiplaintiff BioZorb tissue marker lawsuit, all indicating that they suffered injuries and complications due to the recalled device’s defective design. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)
6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: yesterday) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025)
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 4 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)